Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Sees Large Volume Increase – Time to Buy?

Shares of Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) saw unusually-strong trading volume on Monday . Approximately 64,083 shares were traded during mid-day trading, an increase of 146% from the previous session’s volume of 26,033 shares.The stock last traded at $18.12 and had previously closed at $18.40.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the company. UBS Group increased their price target on Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the company a “buy” rating in a research note on Monday, January 27th. William Blair raised Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a report on Tuesday, November 19th.

Telix Pharmaceuticals Limited American Depositary Shares Trading Down 3.0 %

The company’s fifty day moving average price is $17.28.

Telix Pharmaceuticals Limited American Depositary Shares Company Profile

Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.